author-photo

Eric J. Hsu

University of Texas Southwestern Medical Center

4

Papers

6

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (4)
Next-generation cytokines for cancer immunotherapy

2021
Show All
- Source
- Cite
- Save
Citations (2)
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (0)